| 000 | 01905 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514035522.0 | ||
| 264 | 0 | _c20020905 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/s0024-3205(02)01823-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatanabe, Yasuo | |
| 245 | 0 | 0 |
_aInhibitory effects of 1,4-DHP antagonists on synaptic GABA release modulated by BAY-K 8644 in mechanically dissociated rat substantia innominata. _h[electronic resource] |
| 260 |
_bLife sciences _cJul 2002 |
||
| 300 |
_a1103-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium Channel Agonists _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channels, L-Type _xdrug effects |
| 650 | 0 | 4 |
_aDihydropyridines _xpharmacology |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
| 650 | 0 | 4 |
_aGABA Antagonists _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type I |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 |
_aPresynaptic Terminals _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSubstantia Innominata _xphysiology |
| 650 | 0 | 4 |
_aSynapses _xdrug effects |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aWang, Zhi Ming | |
| 700 | 1 | _aRhee, Jeong Seop | |
| 700 | 1 | _aLawlor, George F | |
| 700 | 1 | _aIshibashi, Hitoshi | |
| 700 | 1 | _aAkaike, Norio | |
| 773 | 0 |
_tLife sciences _gvol. 71 _gno. 10 _gp. 1103-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0024-3205(02)01823-4 _zAvailable from publisher's website |
| 999 |
_c11989501 _d11989501 |
||